Onward Medical N.V. (ONWRF)
OTCMKTS
· Delayed Price · Currency is USD
4.430
-0.320 (-6.74%)
At close: Apr 11, 2025
Onward Medical Company Description
Onward Medical N.V., a medical technology company, develops implantable neuro-stimulation Systems and non-invasive systems for electrical stimulation of specific areas of the spinal cord.
The company engages in developing ARCEX, a transcutaneous system designed to improve upper extremity strength, function, and other symptoms in people with spinal cord injury (SCI); ARCIM, a minimally invasive implantable system to address blood pressure instability and other symptoms in people with SCI; and ARCBCI, which adds an implantable bran-computer interface to the ARCIM to restore thought-driven movement of the upper and lower limbs.
Onward Medical N.V. was founded in 2014 and is headquartered in Eindhoven, Netherlands.
Onward Medical N.V.
Country | Netherlands |
Founded | 2014 |
Industry | Surgical and Medical Instruments and Apparatus |
Employees | 99 |
CEO | David Marver |
Contact Details
Address: Schimmelt 2 Eindhoven, NL-5656 Netherlands | |
Website | onwd.com |
Stock Details
Ticker Symbol | ONWRF |
Exchange | OTCMKTS |
Fiscal Year | January - December |
Reporting Currency | EUR |
SIC Code | 3841 |
Key Executives
Name | Position |
---|---|
David Marver | Chief Executive Officer |
Khaled Bahi | Chief Financial Officer |
Robert Odell | Chief Operating Officer |